Cargando…

Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement

OBJECTIVES: Quality improvement (QI) initiatives based on data from international registries have been reported previously; however, there is a lack of information on the impact on the costs of medical care associated with the use of these tools. METHODS: Patients admitted due to myocardial infarcti...

Descripción completa

Detalles Bibliográficos
Autores principales: de Barros, Pedro Gabriel Melo, Li, John, Tremblay, Christine, Okada, Mariana Yumi, Sznejder, Henry, Furlan, Valter, Vasconcellos, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442399/
https://www.ncbi.nlm.nih.gov/pubmed/32876109
http://dx.doi.org/10.6061/clinics/2020/e1708
_version_ 1783573448608448512
author de Barros, Pedro Gabriel Melo
Li, John
Tremblay, Christine
Okada, Mariana Yumi
Sznejder, Henry
Furlan, Valter
Vasconcellos, Rafael
author_facet de Barros, Pedro Gabriel Melo
Li, John
Tremblay, Christine
Okada, Mariana Yumi
Sznejder, Henry
Furlan, Valter
Vasconcellos, Rafael
author_sort de Barros, Pedro Gabriel Melo
collection PubMed
description OBJECTIVES: Quality improvement (QI) initiatives based on data from international registries have been reported previously; however, there is a lack of information on the impact on the costs of medical care associated with the use of these tools. METHODS: Patients admitted due to myocardial infarction (MI), included in the ACTION Registry® and CathPCI Registry®, in a private Brazilian hospital (i.e., the reference hospital) were analyzed. The costs of care of these patients were compared to the costs of MI admissions in nine similar hospitals not included in the same QI program. Regression models were used to analyze the cost change over time between the two groups of hospitals. Readmission rates were compared using logistic regression, adjusting for the same variables as in the cost model. RESULTS: Overall, the annual medical cost inflation in Brazil was higher than the annual cost trend in the reference hospital during the period of analysis. Moreover, the annual in-hospital costs indicate that the reference hospital has a statistically significant 6% lower cost trend for patients with acute MI, compared to patients with the same diagnostic code in the comparison hospitals group, in an adjusted analysis (p-value=0.041). Using multivariable analysis, the readmission rates were also found to be significantly lower in the reference hospital than in the comparison hospitals, with an odds ratio of 0.68 (p-value=0.042). CONCLUSION: The use of the NCDR® as a benchmark to guide QI programs outside the United States was associated with the positive impact of bending the cost curve to below that of national medical inflation and the comparison hospitals’ costs, with a lower incidence of hospital readmission.
format Online
Article
Text
id pubmed-7442399
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Faculdade de Medicina / USP
record_format MEDLINE/PubMed
spelling pubmed-74423992020-09-02 Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement de Barros, Pedro Gabriel Melo Li, John Tremblay, Christine Okada, Mariana Yumi Sznejder, Henry Furlan, Valter Vasconcellos, Rafael Clinics (Sao Paulo) Original Article OBJECTIVES: Quality improvement (QI) initiatives based on data from international registries have been reported previously; however, there is a lack of information on the impact on the costs of medical care associated with the use of these tools. METHODS: Patients admitted due to myocardial infarction (MI), included in the ACTION Registry® and CathPCI Registry®, in a private Brazilian hospital (i.e., the reference hospital) were analyzed. The costs of care of these patients were compared to the costs of MI admissions in nine similar hospitals not included in the same QI program. Regression models were used to analyze the cost change over time between the two groups of hospitals. Readmission rates were compared using logistic regression, adjusting for the same variables as in the cost model. RESULTS: Overall, the annual medical cost inflation in Brazil was higher than the annual cost trend in the reference hospital during the period of analysis. Moreover, the annual in-hospital costs indicate that the reference hospital has a statistically significant 6% lower cost trend for patients with acute MI, compared to patients with the same diagnostic code in the comparison hospitals group, in an adjusted analysis (p-value=0.041). Using multivariable analysis, the readmission rates were also found to be significantly lower in the reference hospital than in the comparison hospitals, with an odds ratio of 0.68 (p-value=0.042). CONCLUSION: The use of the NCDR® as a benchmark to guide QI programs outside the United States was associated with the positive impact of bending the cost curve to below that of national medical inflation and the comparison hospitals’ costs, with a lower incidence of hospital readmission. Faculdade de Medicina / USP 2020-08-21 2020 /pmc/articles/PMC7442399/ /pubmed/32876109 http://dx.doi.org/10.6061/clinics/2020/e1708 Text en Copyright © 2020 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Original Article
de Barros, Pedro Gabriel Melo
Li, John
Tremblay, Christine
Okada, Mariana Yumi
Sznejder, Henry
Furlan, Valter
Vasconcellos, Rafael
Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement
title Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement
title_full Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement
title_fullStr Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement
title_full_unstemmed Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement
title_short Cost Modifications during the Early Years of the Use of the National Cardiovascular Data Registry for Quality Improvement
title_sort cost modifications during the early years of the use of the national cardiovascular data registry for quality improvement
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442399/
https://www.ncbi.nlm.nih.gov/pubmed/32876109
http://dx.doi.org/10.6061/clinics/2020/e1708
work_keys_str_mv AT debarrospedrogabrielmelo costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement
AT lijohn costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement
AT tremblaychristine costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement
AT okadamarianayumi costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement
AT sznejderhenry costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement
AT furlanvalter costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement
AT vasconcellosrafael costmodificationsduringtheearlyyearsoftheuseofthenationalcardiovasculardataregistryforqualityimprovement